Trial
NCT04100590
Eye Tracking as a Biomarker of Cannabis Effects
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Cannabis Use
Intervention
Cannabis
Why stopped
During a piloting phase with our staff, the technology/eye-tracking device did not collect outcomes as expected.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-30